Association between high body mass index and prognosis of patients with early-stage breast cancer: A systematic review and meta-analysis

Zhoujuan Li , Guoshuang Shen , Mingqiang Shi , Yonghui Zheng, Yumei Guan, Yuanfang Xin, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
{"title":"Association between high body mass index and prognosis of patients with early-stage breast cancer: A systematic review and meta-analysis","authors":"Zhoujuan Li ,&nbsp;Guoshuang Shen ,&nbsp;Mingqiang Shi ,&nbsp;Yonghui Zheng,&nbsp;Yumei Guan,&nbsp;Yuanfang Xin,&nbsp;Miaozhou Wang,&nbsp;Fuxing Zhao,&nbsp;Dengfeng Ren,&nbsp;Jiuda Zhao","doi":"10.1016/j.cpt.2023.03.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>A high body mass index (BMI) can indicate overweight or obesity and is a crucial risk factor for breast cancer survivors. However, the association between high BMI and prognosis in early-stage breast cancer (EBC) remains unclear. We aimed to assess the effects of high BMI on the prognosis of patients with EBC.</p></div><div><h3>Methods</h3><p>The PubMed, Embase, and Cochrane Library databases and proceedings of major oncological conferences related to the effects of BMI on the prognosis of breast cancer were searched up to November 2021. Fixed- and random-effects models were used for meta-analyses. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) for disease-free survival (DFS) and overall survival (OS) were extracted from the included literature.</p></div><div><h3>Results</h3><p>Twenty retrospective cohort studies with 33,836 patients with EBC were included. Overweight patients had worse DFS (HR: 1.16, 95% CI: 1.05–1.27, <em>P</em> = 0.002) and OS (HR: 1.20; 95% CI: 1.09–1.33, <em>P</em> &lt; 0.001). Obesity also had adverse effects on DFS (HR: 1.17, 95% CI: 1.07–1.29, <em>P</em> = 0.001) and OS (HR: 1.30, 95% CI: 1.17–1.45, <em>P</em> &lt; 0.001). Likewise, patients with high BMI had worse DFS (HR: 1.16, 95% CI: 1.08–1.26, <em>P</em> &lt; 0.001) and OS (HR: 1.25, 95% CI: 1.14–1.39, <em>P</em> &lt; 0.001). In subgroup analyses, overweight had adverse effects on DFS (HR: 1.11, 95% CI: 1.04–1.18, <em>P</em> = 0.001) and OS (HR: 1.18, 95% CI: 1.11–1.26, <em>P</em> &lt; 0.001) in multivariate analyses, whereas the relationship that overweight had negative effects on DFS (HR: 1.21, 95% CI: 0.99–1.48, <em>P</em> = 0.058) and OS (HR: 1.39, 95% CI: 0.92–2.10, <em>P</em> = 0.123) was not statistically significant in univariate analysis. By contrast, obesity had adverse effects on DFS (HR: 1.21, 95% CI: 1.06–1.38, <em>P</em> = 0.004 and HR: 1.14, 95% CI: 1.08–1.22, <em>P</em> &lt; 0.001) and OS (HR: 1.33, 95% CI: 1.15–1.54, <em>P</em> &lt; 0.001 and HR: 1.23, 95% CI: 1.15–1.31, <em>P</em> &lt; 0.001) in univariate and multivariate analyses, respectively.</p></div><div><h3>Conclusions</h3><p>Compared with normal weight, increased body weight (overweight, obesity, and high BMI) led to worse DFS and OS in patients with EBC. Once validated, these results should be considered in the development of prevention programs.</p></div>","PeriodicalId":93920,"journal":{"name":"Cancer pathogenesis and therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer pathogenesis and therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949713223000204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background

A high body mass index (BMI) can indicate overweight or obesity and is a crucial risk factor for breast cancer survivors. However, the association between high BMI and prognosis in early-stage breast cancer (EBC) remains unclear. We aimed to assess the effects of high BMI on the prognosis of patients with EBC.

Methods

The PubMed, Embase, and Cochrane Library databases and proceedings of major oncological conferences related to the effects of BMI on the prognosis of breast cancer were searched up to November 2021. Fixed- and random-effects models were used for meta-analyses. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) for disease-free survival (DFS) and overall survival (OS) were extracted from the included literature.

Results

Twenty retrospective cohort studies with 33,836 patients with EBC were included. Overweight patients had worse DFS (HR: 1.16, 95% CI: 1.05–1.27, P = 0.002) and OS (HR: 1.20; 95% CI: 1.09–1.33, P < 0.001). Obesity also had adverse effects on DFS (HR: 1.17, 95% CI: 1.07–1.29, P = 0.001) and OS (HR: 1.30, 95% CI: 1.17–1.45, P < 0.001). Likewise, patients with high BMI had worse DFS (HR: 1.16, 95% CI: 1.08–1.26, P < 0.001) and OS (HR: 1.25, 95% CI: 1.14–1.39, P < 0.001). In subgroup analyses, overweight had adverse effects on DFS (HR: 1.11, 95% CI: 1.04–1.18, P = 0.001) and OS (HR: 1.18, 95% CI: 1.11–1.26, P < 0.001) in multivariate analyses, whereas the relationship that overweight had negative effects on DFS (HR: 1.21, 95% CI: 0.99–1.48, P = 0.058) and OS (HR: 1.39, 95% CI: 0.92–2.10, P = 0.123) was not statistically significant in univariate analysis. By contrast, obesity had adverse effects on DFS (HR: 1.21, 95% CI: 1.06–1.38, P = 0.004 and HR: 1.14, 95% CI: 1.08–1.22, P < 0.001) and OS (HR: 1.33, 95% CI: 1.15–1.54, P < 0.001 and HR: 1.23, 95% CI: 1.15–1.31, P < 0.001) in univariate and multivariate analyses, respectively.

Conclusions

Compared with normal weight, increased body weight (overweight, obesity, and high BMI) led to worse DFS and OS in patients with EBC. Once validated, these results should be considered in the development of prevention programs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高体重指数与早期癌症患者预后的相关性:系统综述和荟萃分析
背景高体重指数(BMI)可表示超重或肥胖,是癌症幸存者的重要危险因素。然而,高BMI与早期癌症(EBC)预后之间的关系仍不清楚。我们旨在评估高BMI对EBC患者预后的影响。方法检索截至2021年11月的PubMed、Embase和Cochrane图书馆数据库以及与BMI对癌症预后影响相关的主要肿瘤会议记录。固定效应和随机效应模型用于荟萃分析。从纳入的文献中提取无病生存期(DFS)和总生存期(OS)的合并危险比(HR)和95%置信区间(CI)。结果纳入20项回顾性队列研究,共33836例EBC患者。超重患者的DFS(HR:1.16,95%CI:1.05–1.27,P=0.002)和OS(HR:1.20;95%CI:1.09–1.33,P<;0.001)更差。肥胖对DFS(HR:1.17,95%CI:1.07–1.29,P=0.001)和OS也有不良影响(HR:1.30,95%CI:1.17–1.45,P>;0.001)。同样,高BMI患者的DFS(HR:1.16,95%CI:1.08–1.26,P<;0.001)和OS(HR:1.25,95%CI:1.14–1.39,P>;0.001)更差。在亚组分析中,超重对多变量分析中的DFS(HR:1.11,95%CI:1.04–1.18,P=0.001)和OS,而超重对DFS(HR:1.21,95%CI:0.99–1.48,P=0.058)和OS(HR:1.39,95%CI:0.92–2.10,P=0.023)产生负面影响的关系在单变量分析中没有统计学意义。相比之下,在单变量和多变量分析中,肥胖分别对DFS(HR:1.21,95%CI:1.06-1.38,P=0.004和HR:1.14,95%CI:1.08-1.22,P<;0.001)和OS(HR:1.33,95%CI:1.15-1.54,P>;0.001和HR:1.23,95%CI+1.15-1.31,P<!0.001)产生不良影响。结论与正常体重相比,体重增加(超重、肥胖和高BMI)会导致EBC患者的DFS和OS恶化。一旦得到验证,在制定预防方案时应考虑这些结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer pathogenesis and therapy
Cancer pathogenesis and therapy Surgery, Radiology and Imaging, Cancer Research, Oncology
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
54 days
期刊最新文献
Table of Contents Cover Corrigendum to “Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology” [Cancer Pathog Ther. 2024;2:205–211] Table of Contents Current and future perspectives on the regulation and functions of miR-545 in cancer development
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1